ChemicalsLarge capRs 57,876 crRs 18.4 cr traded a dayManufacturing
Close on 10 September 2026
1,961.90
−0.04%
52-week range33% of the way up
1,745.602,408.20
Market cap
57,876 cr
P/E (TTM)
34.8×
industry 36×
EPS (TTM)
56.43
Revenue YoY
+15.9%
Q1 FY27
Profit YoY
-23.9%
Net margin
4.7%
-2.4pt vs a year ago
Growth trend
+114.7pt
vs last quarter’s YoY
1 month
-5.4%
Below 52w high
22.7%
RSI (14)
44
Daily swing
2.3%
average true range
Volume
0.3×
vs 20-day average
Traded
Rs 18 cr
median day
Close200-day averageMaterial filing
260 sessions · hover for the filing behind a move
Key metrics
each ranked against every stock scanned tonight
Above the 200-day average
Below the median
-5.6%
One-year return
Below the median
-13.7%
Return on capital employed
n/a
Debt to equity
n/a
Profitable quarters, last four
of the last four reported
4 of 4
Cash conversion
cash from operations against reported profit
n/a
Revenue growth, year on year
latest reported quarter
+15.9%
Below the 52-week high
from the highest close of the year
-18.5%
1 week
+1.58%
1 month
−5.37%
3 months
−1.23%
6 months
−3.11%
1 year
−13.69%
The read
written from the numbers on this page
The evidence is mixed2 supporting, 3 against, 0 worth knowing
Supporting
matches consistently growing and profitable, which has beaten the market by +0.51 points over 20 sessions across 117,484 past signals
revenue grew 16% year on year in the quarter ending 30 June 2026
Against
trading 6% below its 200-day average
down 14% over twelve months
net margin has narrowed from 8.2% to 4.7% across four quarters
Worth knowing
nothing the data supports either way
COROMANDEL sits in Manufacturing — worth checking whether the whole group is moving together or whether this name is doing it alone.
What would change this read: a close back above 2,078, its 200-day average.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.
What is working, what is not
from the filings and from the price, with the figure behind every line
Working1
Revenue rose 15.9% year on year, from Rs 7,042 cr to Rs 8,165 cr.
+15.9%Rs 7,042 crRs 8,165 cr
Needs watching4
Profit grew slower than revenue, -23.9% against +15.9%.
-23.9%+15.9%
Net profit -23.9% year on year, Rs 502 cr to Rs 382 cr.
-23.9%Rs 502 crRs 382 cr
Net margin fell from 7.1% to 4.7%.
7.1%4.7%
Trading 5.6% below its 200-day average.
-5.6%
Every figure here is computed — from the company’s own filings, or from its own closing prices. Wording of 2 of these 4 filing lines was drafted by a language model, which is given the figures and may not introduce another — any sentence containing a number that did not come from the filings is discarded before it reaches this page.
How it has performed
price return over each window, beside the median NSE stock over the same days
What the scans say today
2 of 47 matched on 10 Sep
COROMANDEL matches 2 of the 47 scans today, across 2 different kinds of evidence.
COROMANDEL trades at 35× trailing earnings, close to its median of 33× over this window. The band runs from the 5th to the 95th percentile, so single-day spikes do not set the edges.
This window is short by the standards of valuation history — it begins where four quarters of filed earnings first exist. A stock can look cheap against two years and expensive against ten.
Other filing filings were typically +0.01pt vs the market over the next 5 sessions (n=17,202)
The business
from the company’s filed results
Everything below is taken from the company’s own quarterly filing with the exchange — the XBRL document it submitted, not a vendor’s summary of it. Figures in rupees crore.
RevenueNet profit, drawn inside its revenue barNet margin, own scale belowrupees crore, per quarter as filed. Revenue bars start at zero.
Going for it
revenue grew 16% against the same quarter a year earlier
net margin widened from 1.9% to 4.7%
Going against it
profit dropped 24% year on year
Quarter-by-quarter numbers, as filed
Quarter
Revenue
Profit before tax
Net profit
EPS
Net margin
Q1 FY27
30 Jun · consolidated
8,165
514
382
12.93
4.7%
Q4 FY26
31 Mar · consolidated
60
2
1
4.75
1.9%
Q3 FY26
31 Dec · consolidated
8,779
653
488
17.17
5.6%
Q2 FY26
30 Sep · consolidated
9,654
1,059
793
27.34
8.2%
Q1 FY26
30 Jun · consolidated
7,042
677
502
17.15
7.1%
Q4 FY25
31 Mar · consolidated
4,988
747
578
19.70
11.6%
Quarterly filings are unaudited unless stated. Consolidated figures are used where the company files both. A single quarter is a noisy thing — the trend across the column is worth more than the top row.
Where the price stands
the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average-2.9%
Versus 200-day average-5.6%
Below 52-week high-18.5%
Above 52-week low+12.4%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)44.0
Higher closes in last 53 of 5
Six-month return−3.11%
Risk and liquidity
What a position costs to hold and to exit. Position sizing starts with the daily swing, not with conviction.
Typical daily swing (ATR)2.33%
Volume versus 20-day0.3x
Median daily turnoverRs 18.4 cr
Peers
Chemicals · 44 classified companies
COROMANDEL trades at 34.8× trailing earnings against an industry median of 36.0× across 41 other classified companies in its industry — priced roughly in line with them. A multiple is a statement about expectations, not about quality: cheap usually means the market expects less, and it is often right.